OpenURL Connection Search

Select item for more details and to access through your institution.

Clinical Characteristics and Prognosis of Patients With Advanced Non-Small-cell Lung Cancer Who Are Ineligible for Clinical Trials.
Published in:
2018
By:
- Hayato Kawachi;
- Daichi Fujimoto;
- Takeshi Morimoto;
- Munehiro Ito;
- Shunsuke Teraoka;
- Yuki Sato;
- Kazuma Nagata;
- Atsushi Nakagawa;
- Kojiro Otsuka;
- Keisuke Tomii;
- Kawachi, Hayato;
- Fujimoto, Daichi;
- Morimoto, Takeshi;
- Ito, Munehiro;
- Teraoka, Shunsuke;
- Sato, Yuki;
- Nagata, Kazuma;
- Nakagawa, Atsushi;
- Otsuka, Kojiro;
- Tomii, Keisuke
Publication type:
journal article
Impact of the response to platinum-based chemotherapy on the second-line immune checkpoint inhibitor monotherapy in non-small cell lung cancer with PD-L1 expression ≤49%: a multicenter retrospective study.
Published in:
Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1303543
By:
- Akihiro Yoshimura;
- Takayuki Takeda;
- Nobutaka Kataoka;
- Keiko Tanimura;
- Mototaka Fukui;
- Yusuke Chihara;
- Shota Takei;
- Hayato Kawachi;
- Kentaro Nakanishi;
- Yuta Yamanaka;
- Nobuyo Tamiya;
- Ryoichi Honda;
- Naoko Okura;
- Takahiro Yamada;
- Kiyoaki Uryu;
- Junji Murai;
- Shinsuke Shiotsu;
- Hiroshige Yoshioka;
- Tadaaki Yamada;
- Takayasu Kurata
Publication type:
Article
Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in EGFR exon 19 deletion-positive treatment-naïve non-small cell lung cancer with high PD-L1 expression (SPIRAL-3D study).
Published in:
Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231177022
By:
- Kawachi, Hayato;
- Yamada, Tadaaki;
- Yoshimura, Akihiro;
- Morimoto, Kenji;
- Iwasaku, Masahiro;
- Tokuda, Shinsaku;
- Kim, Young Hak;
- Shimose, Takayuki;
- Takayama, Koichi
Publication type:
Article
Efficacy and safety of ramucirumab and docetaxel in previously treated patients with squamous cell lung cancer: a multicenter retrospective cohort study.
Published in:
Investigational New Drugs, 2022, v. 40, n. 3, p. 634, doi. 10.1007/s10637-022-01214-w
By:
- Kawachi, Hayato;
- Tamiya, Motohiro;
- Matsumoto, Kinnosuke;
- Tamiya, Akihiro;
- Yanase, Takafumi;
- Tanizaki, Satoshi;
- Kumagai, Toru
Publication type:
Article
Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab.
Published in:
Investigational New Drugs, 2021, v. 39, n. 1, p. 232, doi. 10.1007/s10637-020-00966-7
By:
- Tamiya, Motohiro;
- Kunimasa, Kei;
- Nishino, Kazumi;
- Matsumoto, Shingo;
- Kawachi, Hayato;
- Kuno, Kika;
- Inoue, Takako;
- Kuhara, Hanako;
- Imamura, Fumio;
- Goto, Koichi;
- Kumagai, Toru
Publication type:
Article
Association between metastatic sites and first-line pembrolizumab treatment outcome for advanced non–small cell lung cancer with high PD-L1 expression: a retrospective multicenter cohort study.
Published in:
Investigational New Drugs, 2020, v. 38, n. 1, p. 211, doi. 10.1007/s10637-019-00882-5
By:
- Kawachi, Hayato;
- Tamiya, Motohiro;
- Tamiya, Akihiro;
- Ishii, Seigo;
- Hirano, Katsuya;
- Matsumoto, Hirotaka;
- Fukuda, Yasushi;
- Yokoyama, Toshihide;
- Kominami, Ryota;
- Fujimoto, Daichi;
- Hosoya, Kazutaka;
- Suzuki, Hidekazu;
- Hirashima, Tomonori;
- Kanazu, Masaki;
- Sawa, Nobuhiko;
- Uchida, Junji;
- Morita, Mitsunori;
- Makio, Takeshi;
- Hara, Satoshi;
- Kumagai, Toru
Publication type:
Article
Early depth of tumor shrinkage and treatment outcomes in non-small cell lung cancer treated using Nivolumab.
Published in:
Investigational New Drugs, 2019, v. 37, n. 6, p. 1257, doi. 10.1007/s10637-019-00770-y
By:
- Kawachi, Hayato;
- Fujimoto, Daichi;
- Morimoto, Takeshi;
- Hosoya, Kazutaka;
- Sato, Yuki;
- Kogo, Mariko;
- Nagata, Kazuma;
- Nakagawa, Atsushi;
- Tachikawa, Ryo;
- Tomii, Keisuke
Publication type:
Article
First-Line Chemoimmunotherapy versus Sequential Platinum-Based Chemotherapy Followed by Immunotherapy in Patients with Non-Small Cell Lung Cancer with ≤49% Programmed Death-Ligand 1 Expression: A Real-World Multicenter Retrospective Study.
Published in:
Cancers, 2023, v. 15, n. 20, p. 4988, doi. 10.3390/cancers15204988
By:
- Tanimura, Keiko;
- Takeda, Takayuki;
- Kataoka, Nobutaka;
- Yoshimura, Akihiro;
- Nakanishi, Kentaro;
- Yamanaka, Yuta;
- Yoshioka, Hiroshige;
- Honda, Ryoichi;
- Uryu, Kiyoaki;
- Fukui, Mototaka;
- Chihara, Yusuke;
- Takei, Shota;
- Kawachi, Hayato;
- Yamada, Tadaaki;
- Tamiya, Nobuyo;
- Okura, Naoko;
- Yamada, Takahiro;
- Murai, Junji;
- Shiotsu, Shinsuke;
- Kurata, Takayasu
Publication type:
Article
Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non−Small Cell Lung Cancer.
Published in:
JAMA Network Open, 2023, v. 6, n. 7, p. e2322915, doi. 10.1001/jamanetworkopen.2023.22915
By:
- Kawachi, Hayato;
- Yamada, Tadaaki;
- Tamiya, Motohiro;
- Negi, Yoshiki;
- Goto, Yasuhiro;
- Nakao, Akira;
- Shiotsu, Shinsuke;
- Tanimura, Keiko;
- Takeda, Takayuki;
- Okada, Asuka;
- Harada, Taishi;
- Date, Koji;
- Chihara, Yusuke;
- Hasegawa, Isao;
- Tamiya, Nobuyo;
- Ishida, Masaki;
- Katayama, Yuki;
- Morimoto, Kenji;
- Iwasaku, Masahiro;
- Tokuda, Shinsaku
Publication type:
Article
Sequencing strategies with ramucirumab and docetaxel following prior treatments for advanced non-small cell lung cancer: a multicenter retrospective cohort study.
Published in:
European Journal of Clinical Pharmacology, 2023, v. 79, n. 4, p. 503, doi. 10.1007/s00228-023-03452-0
By:
- Tanizaki, Satoshi;
- Matsumoto, Kinnosuke;
- Tamiya, Akihiro;
- Taniguchi, Yoshihiko;
- Matsuda, Yoshinobu;
- Uchida, Junji;
- Ueno, Kiyonobu;
- Kawachi, Hayato;
- Tamiya, Motohiro;
- Yanase, Takafumi;
- Suzuki, Hidekazu;
- Okishio, Kyoichi
Publication type:
Article
Ineligibility for the PACIFIC trial in unresectable stage III non-small cell lung cancer patients.
Published in:
2019
By:
- Hosoya, Kazutaka;
- Fujimoto, Daichi;
- Kawachi, Hayato;
- Sato, Yuki;
- Kogo, Mariko;
- Nagata, Kazuma;
- Nakagawa, Atsushi;
- Tachikawa, Ryo;
- Hiraoka, Shinya;
- Kokubo, Masaki;
- Tomii, Keisuke
Publication type:
journal article
Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer.
Published in:
NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00350-7
By:
- Katayama, Yuki;
- Yamada, Tadaaki;
- Tanimura, Keiko;
- Tokuda, Shinsaku;
- Morimoto, Kenji;
- Hirai, Soichi;
- Matsui, Yohei;
- Nakamura, Ryota;
- Ishida, Masaki;
- Kawachi, Hayato;
- Yoneda, Kazue;
- Hosoya, Kazutaka;
- Tsuji, Takahiro;
- Ozasa, Hiroaki;
- Yoshimura, Akihiro;
- Iwasaku, Masahiro;
- Kim, Young Hak;
- Horinaka, Mano;
- Sakai, Toshiyuki;
- Utsumi, Takahiro
Publication type:
Article
Efficacy and Safety of Docetaxel plus Ramucirumab for Patients with Pretreated Advanced or Recurrent Non-small Cell Lung Cancer: Focus on Older Patients.
Published in:
Targeted Oncology, 2024, v. 19, n. 3, p. 411, doi. 10.1007/s11523-024-01045-0
By:
- Onoi, Keisuke;
- Yamada, Tadaaki;
- Morimoto, Kenji;
- Kawachi, Hayato;
- Tsutsumi, Rei;
- Takeda, Takayuki;
- Okada, Asuka;
- Tamiya, Nobuyo;
- Chihara, Yusuke;
- Shiotsu, Shinsuke;
- Takemura, Yoshizumi;
- Yamada, Takahiro;
- Hasegawa, Isao;
- Katayama, Yuki;
- Iwasaku, Masahiro;
- Tokuda, Shinsaku;
- Takayama, Koichi
Publication type:
Article
Chemoimmunotherapy Versus Pembrolizumab as a First-Line Treatment for Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression: Focus on the Role of Performance Status.
Published in:
Targeted Oncology, 2023, v. 18, n. 6, p. 915, doi. 10.1007/s11523-023-01012-1
By:
- Morimoto, Kenji;
- Yamada, Tadaaki;
- Kawachi, Hayato;
- Tamiya, Motohiro;
- Negi, Yoshiki;
- Goto, Yasuhiro;
- Nakao, Akira;
- Shiotsu, Shinsuke;
- Tanimura, Keiko;
- Takeda, Takayuki;
- Okada, Asuka;
- Harada, Taishi;
- Date, Koji;
- Chihara, Yusuke;
- Hasegawa, Isao;
- Tamiya, Nobuyo;
- Nishioka, Naoya;
- Katayama, Yuki;
- Iwasaku, Masahiro;
- Tokuda, Shinsaku
Publication type:
Article
Prospective Observational Study of Ramucirumab Plus Docetaxel After Combined Chemoimmunotherapy in Patients With Non‐Small‐Cell Lung Cancer.
Published in:
Oncologist, 2024, v. 29, n. 5, p. e681, doi. 10.1093/oncolo/oyae001
By:
- Katayama, Yuki;
- Yamada, Tadaaki;
- Sawada, Ryo;
- Kawachi, Hayato;
- Morimoto, Kenji;
- Watanabe, Satoshi;
- Watanabe, Kageaki;
- Takeda, Takayuki;
- Chihara, Yusuke;
- Shiotsu, Shinsuke;
- Hibino, Makoto;
- Harada, Taishi;
- Nishioka, Naoya;
- Iwasaku, Masahiro;
- Tokuda, Shinsaku;
- Takayama, Koichi
Publication type:
Article
Unraveling the influence of TTF-1 expression on immunotherapy outcomes in PD-L1-high non-squamous NSCLC: a retrospective multicenter study.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1399889
By:
- Naoya Nishioka;
- Hayato Kawachi;
- Tadaaki Yamada;
- Motohiro Tamiya;
- Yoshiki Negi;
- Yasuhiro Goto;
- Akira Nakao;
- Shinsuke Shiotsu;
- Keiko Tanimura;
- Takayuki Takeda;
- Asuka Okada;
- Taishi Harada;
- Koji Date;
- Yusuke Chihara;
- Isao Hasegawa;
- Nobuyo Tamiya;
- Taiki Masui;
- Natsuki Sai;
- Masaki Ishida;
- Yuki Katayama
Publication type:
Article
Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50%.
Published in:
Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1348034
By:
- Shota Takei;
- Hayato Kawachi;
- Tadaaki Yamada;
- Motohiro Tamiya;
- Yoshiki Negi;
- Yasuhiro Goto;
- Akira Nakao;
- Shinsuke Shiotsu;
- Keiko Tanimura;
- Takayuki Takeda;
- Asuka Okada;
- Taishi Harada;
- Koji Date;
- Yusuke Chihara;
- Isao Hasegawa;
- Nobuyo Tamiya;
- Yuki Katayama;
- Naoya Nishioka;
- Kenji Morimoto;
- Masahiro Iwasaku
Publication type:
Article
Initial AXL and MCL‐1 inhibition contributes to abolishing lazertinib tolerance in EGFR‐mutant lung cancer cells.
Published in:
Cancer Science, 2024, v. 115, n. 10, p. 3333, doi. 10.1111/cas.16292
By:
- Matsui, Yohei;
- Yamada, Tadaaki;
- Katayama, Yuki;
- Hirai, Soichi;
- Sawada, Ryo;
- Tachibana, Yusuke;
- Ishida, Masaki;
- Kawachi, Hayato;
- Nakamura, Ryota;
- Nishioka, Naoya;
- Morimoto, Kenji;
- Iwasaku, Masahiro;
- Horinaka, Mano;
- Sakai, Toshiyuki;
- Tokuda, Shinsaku;
- Takayama, Koichi
Publication type:
Article
Nationwide data from comprehensive genomic profiling assays for detecting driver oncogenes in non‐small cell lung cancer.
Published in:
Cancer Science, 2024, v. 115, n. 5, p. 1656, doi. 10.1111/cas.16130
By:
- Ishida, Masaki;
- Iwasaku, Masahiro;
- Doi, Toshifumi;
- Ishikawa, Takeshi;
- Tachibana, Yusuke;
- Sawada, Ryo;
- Ogura, Yuri;
- Kawachi, Hayato;
- Katayama, Yuki;
- Nishioka, Naoya;
- Morimoto, Kenji;
- Tokuda, Shinsaku;
- Yamada, Tadaaki;
- Takayama, Koichi
Publication type:
Article

Found: 19